Cumberland Pharmaceuticals (CPIX) Shares Outstanding (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Shares Outstanding (Entity) of $15.0 million for Q1 2026, little changed sequentially from $15.0 million in Q4 2025, and little changed YoY from $15.0 million in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Shares Outstanding (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Shares Outstanding (Entity) for 17 years, with the latest figure at $15.0 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) changed 0.15% year-over-year to $15.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.0 million (changed 0.15% YoY) and the FY2025 annual result came in at $15.0 million, up 7.2% from the prior year.
- Shares Outstanding (Entity) steadied at $15.0 million in Q1 2026 per CPIX's latest filing, from $15.0 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $15.0 million in Q1 2026 and troughed at $14.0 million in Q4 2024.
- A 5-year average of $14.5 million and a median of $14.4 million in 2023 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) decreased 2.79% in 2022, then gained 7.2% in 2025.
- Over 5 years, Shares Outstanding (Entity) stood at $14.4 million in 2022, then fell by 1.7% to $14.1 million in 2023, then fell by 1.2% to $14.0 million in 2024, then climbed by 7.2% to $15.0 million in 2025, then rose by 0.18% to $15.0 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $15.0 million, $15.0 million, and $15.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 832.44 Mn |
| 10 | Cumberland Pharmaceuticals | 114.16 Mn | 110.30 Mn | - | 14.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.98 Mn |
| Mar 31, 2026 | 14.96 Mn |
| Dec 31, 2025 | 14.85 Mn |
| Sep 30, 2025 | 14.96 Mn |
| Jun 30, 2025 | 14.96 Mn |
| Mar 31, 2025 | 14.94 Mn |
| Dec 31, 2024 | 14.06 Mn |
| Sep 30, 2024 | 14.05 Mn |
| Jun 30, 2024 | 14.12 Mn |
| Mar 31, 2024 | 14.10 Mn |
| Dec 31, 2023 | 14.30 Mn |
| Sep 30, 2023 | 14.28 Mn |
| Jun 30, 2023 | 14.39 Mn |
| Mar 31, 2023 | 14.36 Mn |
| Dec 31, 2022 | 14.56 Mn |
| Sep 30, 2022 | 14.48 Mn |
| Jun 30, 2022 | 14.69 Mn |
| Mar 31, 2022 | 14.69 Mn |
| Dec 31, 2021 | 14.90 Mn |
| Sep 30, 2021 | 14.88 Mn |